Kala Pharmaceuticals Secures $22,500,000 Series B Financing Round

  • Feed Type
  • Date
    4/23/2014
  • Company Name
    Kala Pharmaceuticals
  • Mailing Address
    100 Beaver St. Waltham, MA 02453 USA
  • Company Description
    Kala Pharmaceuticals, Inc. is a biotechnology company founded upon a proprietary drug delivery technology. By utilizing this unique technology, Kala aims to address unmet therapeutic needs of various diseases and conditions in a fundamentally novel way.
  • Website
    http://www.kalarx.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $22,500,000
  • Transaction Round
    Series B
  • Proceeds Purposes
    The proceeds from the financing will be used to advance clinical development of the company’s loteprednol etabonate MPP (LE-MPP) program.
  • M&A Terms
  • Venture Investor
  • Venture Investor
  • Venture Investor
  • Venture Investor
  • Venture Investor

By posting a comment, you agree to our terms and conditions.